When Selegiline is Prescribed, Stelazine May be Mistakenly Dispensed
Neurol 43:228, Zweig,R.M.&Davis,P.H., 1993
Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's Disease
The Parkinson Study Group, NEJM 328:176-1831993., , 1993
The Antiparkinson Efficacy of Deprenyl Derives from Transient Improvement that is Likely to be Symptomatic
Ann Neurol 32:795-798, Schulzer,M.,et al, 1992
Idiopathic Intracranial Hypertension:Report of Seven Cases
Am J Med 93:391-395, Jain,N.&Rosner,F., 1992
Selegiline as Initial Treatment of De Novo Parkinsonian Patients
Neurol 42:339-343, Myllyla,V.V.,et al, 1992
Deprenyl Effects of Levodopa Pharmacodynamics, Mood, and Free Radical Scavenging
Neurol 42:541-544, Baronti,F.,et al, 1992
Antibodies to Oxidised LDL in Atherosclerosis
Editorial, Lancet 339:899-9001992., , 1992
Serum Concentrations of Vitamins A and E and Early Outcome after Ischaemic Stroke
Lancet 339:1562-1565, DeKeyser,J.,et al, 1992
The Effect of Acetazolamide on Essential Tremor:An Open-Label Trial
Neurol 42:1394-1395, Busenbark,K.,et al, 1992
Treatment of Nocturnal Leg Cramps, A Crossover Trial of Quinine vs Vitamin E
Arch Int Med 152:1877-1880, Connolly,P.S.,et al, 1992
Nerve Agents:A Review
Neurol 42:946-950, Gunderson,C.H.,et al, 1992
A Controlled Trial of Tacrine in Alzheimer's Disease
JAMA 268:2523-2529, 25641992., Farlow,M.,et al, 1992
A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Dissease
NEJM 327:1253-1259, 13061992., Davis,K.L.,et al, 1992
Pyridostigmine Used as a Nerve Agent Pretreatment Under Wartime Conditions
JAMA 266:693-695, Keeler,J.R.,et al, 1991
DATATOP and Clinical Neuromythology IX
Special Correspondence, Neurol 41:771-7771991., , 1991
Acquired Factor VIII Deficiency and Polyradiculoneuropathy
NEJM 324:1139, Garland,L.,et al, 1991
Acetazolamide-Responsive Vestibulocerebellar Syndrome:Clinical & Oculographic Features
Neurol 41:429-433, Baloh,R.W.&Winder,A., 1991
Tacrine in Alzheimer's Disease
Lancet 337:989-992, Eagger,S.A.,et al, 1991
Severe Adverse Interaction Between Pethidine and Selegiline
Lancet 337:246, Zornberg,G.L.,et al, 1991
Aseptic Meningitis Following Cardiac Transplantation:Clinical Characteristics & Relationship to Immunosuppressive Regimen
Neurol 41:249-252, Adair,J.C.,et al, 1991
Treatment of Guillain-Barre Syndrome with Anti-T Cell Monoclonal Antibodies
JNNP 54:51-54, Feasby,T.E., 1991
Management of Injuries Due to Chemical Weapons
BMJ 302:129-130, Murray,V.S.G.&Volans,G.N., 1991
Early Combination of Selegiline and Low-Dose Levodopa as Initial Symptomatic Therapy in Parkinson's Dis
Arch Neurol 48:31-34, Elizan,T.S.,et al, 1991
Chronic Acetazolamide Monotherapy in the Treatment of Juvenile Myoclonic Epilepsy
Neurol 40:1677-1681, Resor,S.R.&Resor,L.D., 1990
Tetrahydroaminoacridine-Lecithin Combination Treatment in Patients with Intermediate-Stage Alzheimer's Disease
NEJM 322:1272-1276, Gauthier,S.,et al, 1990
Neurotoxicity After Treatment with Muromonab-CD3
NEJM 323:487-488, Richards,J.M.,et al, 1990
Pyramid Sale in the Bucket Shop:DATATOP Bottoms Out
Neurol 40:1337-1339, Landau,W.M., 1990
Decreased Efficacy of Levodopa with Carbidopa in Parkinsonian Patients after Adrenal-to-Caudate Implants
Neurol 40:845-846, Tsui,J.K.C.,et al, 1990
Effect of Intramuscular Vitamin E on Mortality and Intracranial Hemorrhage in Neonates of 1000 Grams or Less
Pediatrics 85:578-584, Fish,W.H.,et al, 1990
Vitamin E for Prevention of Perinatal Intracranial Hemorrhage
Pediatrics 85:865-867, Poland,R.L., 1990
OKT3 Encephalopathy
Ann Neurol 28:837-838, Coleman,A.E.&Norman,D.J., 1990
"Stelazine"versus"Selegiline"-A Hazard in Prescription Writing, Letter
NEJM 323:1776, Kurth,M.C.,et al, 1990
Tacrine (tetrahydroaminoacridine; THA) and Lecithin in Senile Dememtia of the Alzheimer Type:A Multicentre Trial
BMJ 300:495-499, Chatellier,G.,et al, 1990
The Rational Management of Idiopathic Intracranial Hypertension
Arch Neurol 46:1049-1051, Corbett,J.J.&Thompson,H.S., 1989
Selegiline Use to Prevent Progression of Parkinson's Disease
Arch Neurol 46:1275-1279, Elizan,T.S.,et al, 1989
Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease
The Parkinson Study Group, NEJM 321:1364-13711989., , 1989
DATATOP:A Multicenter Controlled Clinical Trial in Early Parkinson's Disease
Parkinson Study Group, Arch Neurol 46:1052-10601989., , 1989
Selegiline as an Adjunct to Conventional Levodopa Therapy in Parkinson's Disease
Arch Neurol 46:1280-1283, Elizan,T.S.,et al, 1989
Tetrahydroaminoacridine (THA) in Alzheimer's Disease, Not Ready for Routine Use
BMJ 298:845-846, Graham,T.R.&Lewis,C.T., 1989
Neoplastic Meningitis in Malignant Melanoma:Diagnosis with Monoclonal Antibodies
JNNP 52:881-886, Moseley,R.P.,et al, 1989
Pergolide and Selegiline for Parkinson's Disease
The Medical Letter, 31:81-841989., , 1989
Long-Term Efficacy and Safety of Deprenyl (Selegiline) in Advanced Parkinson's Disease
Neurol 39:1109-1111, Golbe,L.I.,et al, 1989
The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease
Science 245:519-522, Tetrud,J.W.&Langston,W., 1989
Current Theories on the Cause of Parkinson's Disease
JNNP Suppl (June) 52:13-17989., Langston,J.W., 1989
Paroxysmal Cerebellar Ataxia
Aust NZ J Med 19:113-117, Feeney,G.F.&Boyle,R.S., 1989
Long-Term Administration of Oral Physostigmine in Alzheimer's Disease
Neurol 38:1837-1841, Stern,Y.,et al, 1988
Effect of Vitamin E Deficiency on Neurologic Function in Patients with Cystic Fibrosis
J Pediatr 113:637-640, Cynamon,H.A.,et al, 1988
Tardive Dyskinesia
BMJ 296:150-151, Barnes,T.R.E., 1988
Immunotherapy of Multiple Sclerosis
Ann Neurol 23:211-223, Weiner,H.L.&Hafler,D.A., 1988
Nosocomial Aseptic Meningitis Associated with Administration of OKT3
JAMA 259:2002-2005, Martin,M.A.,et al, 1988